BioScience Health Innovations (BHIC) Equity Ratio (2019 - 2025)
Historic Equity Ratio for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to 0.83.
- BioScience Health Innovations' Equity Ratio fell 704.76% to 0.83 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83, marking a year-over-year decrease of 704.76%. This contributed to the annual value of 0.96 for FY2024, which is 142053.4% up from last year.
- BioScience Health Innovations' Equity Ratio amounted to 0.83 in Q3 2025, which was down 704.76% from 0.84 recorded in Q2 2025.
- Over the past 5 years, BioScience Health Innovations' Equity Ratio peaked at 0.96 during Q4 2024, and registered a low of 23.09 during Q2 2021.
- In the last 5 years, BioScience Health Innovations' Equity Ratio had a median value of 0.76 in 2021 and averaged 1.15.
- Per our database at Business Quant, BioScience Health Innovations' Equity Ratio plummeted by 6945178.02% in 2021 and then skyrocketed by 142053.4% in 2024.
- Over the past 5 years, BioScience Health Innovations' Equity Ratio (Quarter) stood at 0.76 in 2021, then increased by 18.18% to 0.9 in 2022, then plummeted by 108.05% to 0.07 in 2023, then surged by 1420.53% to 0.96 in 2024, then fell by 13.41% to 0.83 in 2025.
- Its last three reported values are 0.83 in Q3 2025, 0.84 for Q2 2025, and 0.9 during Q1 2025.